Baxter International BAX Renal Care — Net Sales
Discontinued — last reported Q2 '23
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Baxter International’s 10-Q, filed July 27, 2023, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's renal care — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's renal care — net sales?
- Baxter International (BAX) reported renal care — net sales of $936M in Q2 2023.
- How has Baxter International's renal care — net sales changed year-over-year?
- Baxter International's renal care — net sales increased by 0.5% year-over-year, from $931M to $936M.
- What does renal care — net sales mean?
- Total revenue earned from the company's kidney care and dialysis product line.
- How do you interpret renal care — net sales?
- An increase indicates growing market share or higher patient utilization of renal therapy products, while a decrease may signal competitive pressure or reduced demand for dialysis treatments.
- How does renal care — net sales compare across companies?
- Comparable to dialysis and renal therapy revenue segments reported by major medical device competitors in the nephrology space.